New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 17, 2013
16:43 EDTRADMoody's changes Rite Aid outlook to positive from stable
Moody's Investors Service today changed Rite Aid Corporation's outlook to positive from stable. All existing ratings including its Caa1 Corporate Family Rating and Speculative Grade Liquidity rating of SGL-3 are affirmed.
News For RAD From The Last 14 Days
Check below for free stories on RAD the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 25, 2014
06:02 EDTRADStocks with implied volatility movement; RAD WLT
Stocks with implied volatility movement; Rite Aid (RAD) 59, Walter Energy (WLT) 131 according to iVolatility.
September 24, 2014
11:04 EDTRADOptions with decreasing implied volatility
Subscribe for More Information
09:34 EDTRADActive equity options trading on open
Subscribe for More Information
September 19, 2014
16:24 EDTRADStocks rise after Fed keeps pledge for 'considerable time' before rate hike
Subscribe for More Information
September 18, 2014
16:00 EDTRADOptions Update; September 18, 2014
Subscribe for More Information
12:45 EDTRADOn The Fly: Midday Wrap
Subscribe for More Information
11:55 EDTRADRite Aid falls as drugstore chain trims FY15 view
Subscribe for More Information
10:27 EDTRADOptions with decreasing implied volatility
Subscribe for More Information
09:36 EDTRADActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL YHOO TWTR VVUS RAD PWE WFM TSLA PIR SHLD
09:15 EDTRADRite Aid remains 'optimistic' about FY16
Subscribe for More Information
09:02 EDTRADRite Aid sees current competitive enviornment to remain promotional in FY15
Subscribe for More Information
08:59 EDTRADOn The Fly: Pre-market Movers
Subscribe for More Information
07:04 EDTRADRite Aid cuts FY15 EPS view to 22c-33c, consensus 34c
Based upon current estimates for reimbursement rates and anticipated lower profitability from new generics and generic drugs that recently lost exclusivity, the company is expecting decreases in pharmacy margin in the second half of Fiscal 2015 as compared to its prior estimates and therefore is lowering its guidance for Adjusted EBITDA, net income and net income per diluted share. Previous EPS view was 30c-40c. Cuts FY15 high end of revenue view to $26B-$26.3B from $26B-$26.5B, consensus $26.29B. Now sees FY SSS up 3%-4% over FY14. Sees FY CapEx $525M. Sees adjusted EBITDA $1.2B-$1.275B.
07:02 EDTRADRite Aid reports Q2 EPS 13c, consensus 6c
Subscribe for More Information
September 17, 2014
15:18 EDTRADNotable companies reporting before tomorrow's open
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use